<DOC>
	<DOC>NCT00679640</DOC>
	<brief_summary>The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution</brief_summary>
	<brief_title>Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure patients included in a clinical trial the last 30 days before consultation patients unable to answer the questions for linguistic or cognitive reasons patients who will be difficult to follow during the one year study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>candesartan</keyword>
	<keyword>heart failure</keyword>
	<keyword>cohort study</keyword>
	<keyword>France</keyword>
</DOC>